Bringing together a panel of knowledgeable voices, with an overview of the digital health and medical technology sector, this opening session will consider how the COVID-19 pandemic has accelerated interest in the opportunities that digital health technologies and Medical Device Software offers and how this is being reflected in the industry:

• How has the COVID-19 pandemic accelerated the development and adoption of Medical Device Software to diagnose, treat and manage patients?
• Understanding the developing start-up landscape and the emergence of new health technologies
• What is the impact on existing Medical Device manufacturers?
• How should the industry respond to meet the demand and maximise the opportunity of this moment in time?
• What are some of the potential challenges and how might these be overcome?

Verily Life Sciences is at the convergence of healthcare, data science and technology, with its key focus on building integrated solutions to improve human health.

• Understanding the importance of end-to-end risk management when considering cybersecurity
• Outlining the critical success factors for the integration of risk mitigation techniques
• Sharing examples of how existing cybersecurity mitigations have been integrated into the product lifecycle development and where there is room for further development